Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Revlite Laser System Compared to the Candela Alex TriVantage System Refractory Mixed Type Melasma

NCT01745224 is registered in ClinicalTrials.gov with Cynosure, Inc. as lead sponsor.

NCT NCT01745224
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01745224 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Revlite Laser System Compared to the Candela Alex TriVantage System Refractory Mixed Type Melasma
Lead sponsor
Cynosure, Inc.
Phase
Not applicable
Overall status
Terminated
Start date
July 31, 2012
Completion date
July 31, 2013
Enrollment
4 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

melasma